SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop
6 references·0 citing·21 second hop
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop (2022)Rationale for supporting stepwise access …Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop (2022)Stepwise access to safe plasm…Shortage of plasma-derived products: a looming crisis? (2022)Shortage of plasma-derived pr…Plasma procurement and plasma product safety in light of the COVID ‐19 pandemic from the perspective of the plasma industry (2022)Plasma procurement and plasma…Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID ‐19 pandemic (2020)Supply and demand for plasma‐…Global immunoglobulin supply: steaming towards the iceberg? (2020)Global immunoglobulin supply:…Plasma is a strategic resource (2016)Plasma is a strategic resourceEmerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century (2012)Declining blood collection and utilization in the United States (2016)Progress Toward Strengthening National Blood Transfusion Services — 14 Countries, 2011–2014 (2016)Blood and Blood Components: From Similarities to Differences (2018)Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand (2020)A prospective multicentre study on the safety of long‐term intensive plasmapheresis in donors (SIPLA) (2006)Slowing decline in blood collection and transfusion in the United States – 2017 (2020)Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram (2021)Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium (2023)How much blood is needed? (2010)Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus ( COVID ‐19) pandemic affecting Washington State (2020)Building awareness: Introducing education about blood‐product donation in the school curriculum (2025)Challenges in the management of the blood supply (2013)Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors (2017)Effects of the COVID-19 pandemic on supply and use of blood for transfusion (2020)Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010–2019: A favorable sign of the resiliency of the platelet supply (2023)A rapid review of motives and barriers for living substance of human origin donation and an extended typology (2024)Challenges for Plasma-Derived Medicinal Products (2023)Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries (2023)Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries (2023)Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape (2024)
this work references cited by second hop

References

  • 2020Global immunoglobulin supply: steaming towards the iceberg?93 cited
  • 2020Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID ‐19 pandemic60 cited
  • 2016Plasma is a strategic resource53 cited
  • 2022Shortage of plasma-derived products: a looming crisis?36 cited
  • 2022Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop15 cited
  • 2022Plasma procurement and plasma product safety in light of the COVID ‐19 pandemic from the perspective of the plasma industry11 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work